10X Genomics Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | 20.0 | 29.8 | 22.8 | 35.2 | 48.2 | 50.9 | 59.1 | 53.0 | 35.2 | 34.0 | 17.2 | 10.3 | 6.5 | 8.1 | 12.0 | 11.5 | 8.2 | 10.7 | 7.2 | 3.7 | 4.3 | 2.9 | 1.7 | 2.2 | 2.3 | 3.2 | 4.3 | 8.1 | |
| – | – | – | – | – | – | 10.5 | 17.4 | 14.7 | 22.6 | 15.3 | 20.6 | 26.2 | 27.4 | 20.2 | 20.4 | 10.7 | 6.6 | 4.2 | 5.2 | 8.0 | 8.2 | 6.5 | 9.0 | 6.2 | 3.2 | 3.8 | 2.5 | 1.5 | 1.9 | 1.9 | 2.6 | 3.3 | 6.0 | |
| – | – | – | – | – | – | 18.2 | 28.2 | 21.4 | 33.8 | 45.3 | 48.7 | 57.3 | 51.5 | 33.9 | 32.8 | 16.6 | 9.8 | 6.0 | 7.7 | 11.4 | 10.9 | 7.7 | 10.2 | 6.6 | 3.1 | 3.7 | 2.3 | 1.1 | 1.6 | 1.6 | 2.5 | 3.5 | 7.3 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 22.8 | 24.0 | 160.3 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 109.0 | – | 24.0 | 25.4 | 18.0 | 15.9 | 22.3 | 41.0 | |
| – | – | – | – | – | – | -1.4% | -0.1% | -0.3% | -0.5% | -0.8% | -1.7% | -1.5% | -1.2% | -1.6% | -0.7% | -1.5% | -3.1% | -5.0% | -4.0% | -1.9% | -1.8% | -2.3% | -1.0% | -1.7% | -1.4% | 0.9% | -0.4% | 4.2% | 3.9% | 5.6% | 6.3% | 4.5% | 2.4% | |
| Margins | ||||||||||||||||||||||||||||||||||
| – | – | – | 80.5% | 77.6% | 75.0% | 73.2% | 75.2% | 76.5% | 77.2% | 78.6% | 80.4% | 81.8% | 86.4% | 85.8% | 84.9% | 83.5% | 78.9% | 77.9% | 76.7% | 75.6% | 73.6% | 69.9% | 66.2% | 64.6% | 64.7% | 66.6% | 67.9% | 68.4% | 69.5% | 68.8% | 69.1% | 69.6% | 70.0% | |
| – | – | – | -69.2% | -57.0% | -52.6% | -44.1% | -12.4% | -17.9% | -30.4% | -50.6% | -178.7% | -157.6% | -122.1% | -97.1% | -10.7% | -16.8% | -27.4% | -31.9% | -32.5% | -33.2% | -31.4% | -39.5% | -42.9% | -43.9% | -40.1% | -31.7% | -31.9% | -27.6% | -15.6% | -14.2% | -9.5% | -6.1% | -14.3% | |
| – | – | – | -72.5% | -58.2% | -53.6% | -45.1% | -12.7% | -18.5% | -31.1% | -51.3% | -181.6% | -160.2% | -124.2% | -99.2% | -11.9% | -17.8% | -28.6% | -33.2% | -32.1% | -32.5% | -30.3% | -37.8% | -41.2% | -42.3% | -38.0% | -29.0% | -29.9% | -25.1% | -13.1% | -11.9% | -6.8% | -3.5% | -12.2% | |
| – | – | – | -56.0% | -41.4% | -35.0% | -28.1% | -3.3% | -7.1% | -18.3% | -39.6% | -85.8% | -86.7% | -65.0% | -55.2% | -25.0% | -25.8% | -32.4% | -32.0% | -32.0% | -23.3% | -20.7% | -19.0% | -10.3% | -11.8% | -5.3% | 4.0% | -1.1% | 7.1% | 8.8% | 12.7% | 20.2% | 19.1% | 19.7% | |
| Returns | ||||||||||||||||||||||||||||||||||
| – | – | – | – | -431.8% | -689.0% | -23.6% | -7.4% | -11.9% | -19.9% | -16.3% | -73.4% | -70.9% | -64.2% | -56.9% | -7.1% | -11.0% | -18.2% | -21.6% | -20.6% | -21.7% | -21.7% | -30.0% | -34.4% | -36.8% | -33.1% | -25.3% | -25.7% | -22.2% | -10.9% | -9.7% | -5.5% | -2.8% | -9.1% | |
| – | – | – | -86.6% | – | -67.7% | -17.4% | -5.2% | -8.0% | -13.4% | -12.9% | -58.4% | -55.9% | -51.6% | -46.0% | -5.7% | -8.9% | -14.2% | -16.8% | -16.1% | -17.2% | -17.4% | -23.5% | -26.4% | -28.6% | -25.8% | -19.5% | -19.9% | -17.4% | -8.6% | -7.4% | -4.2% | -2.2% | -7.3% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||
| – | – | -40 | -35 | 65 | -26 | -398 | -394 | -369 | -336 | -764 | -658 | -611 | -617 | -596 | -582 | -305 | -266 | -226 | -211 | -323 | -317 | -301 | -348 | -345 | -369 | -389 | -335 | -368 | -388 | -422 | -463 | -479 | -490 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -6.6 | -5.1 | -17.5 | |
| – | – | -177.0% | -177.0% | – | 9.8% | 73.6% | 69.3% | 67.0% | 67.1% | 79.1% | 79.5% | 78.9% | 80.3% | 80.8% | 80.2% | 80.4% | 78.2% | 77.9% | 78.3% | 79.1% | 80.2% | 78.6% | 76.8% | 77.9% | 77.9% | 77.1% | 77.3% | 78.2% | 78.9% | 76.4% | 76.5% | 80.2% | 80.1% | |
| – | – | – | – | 0.0 | 1.9 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Per Share | ||||||||||||||||||||||||||||||||||
| – | – | – | -7.68 | -6.78 | -6.77 | -1.14 | -0.33 | -0.50 | -0.79 | -1.33 | -5.05 | -4.90 | -4.59 | -4.11 | -0.52 | -0.79 | -1.25 | -1.47 | -1.45 | -1.51 | -1.48 | -1.90 | -2.15 | -2.21 | -2.00 | -1.51 | -1.50 | -1.28 | -0.68 | -0.61 | -0.34 | -0.18 | -0.58 | |
| – | – | – | 10.60 | 11.65 | 12.63 | 2.53 | 2.56 | 2.73 | 2.54 | 2.58 | 2.78 | 3.06 | 3.69 | 4.14 | 4.38 | 4.42 | 4.38 | 4.41 | 4.50 | 4.64 | 4.87 | 5.02 | 5.22 | 5.24 | 5.26 | 5.22 | 5.02 | 5.09 | 5.18 | 5.11 | 5.06 | 4.98 | 4.75 | |
| 0.59 | – | -16.19 | -15.71 | 1.57 | 0.98 | 4.81 | 4.37 | 4.22 | 3.95 | 8.14 | 6.88 | 6.92 | 7.14 | 7.22 | 7.31 | 7.14 | 6.90 | 6.80 | 7.02 | 6.94 | 6.80 | 6.33 | 6.25 | 6.02 | 6.03 | 5.99 | 5.84 | 5.77 | 6.21 | 6.26 | 6.27 | 6.35 | 6.35 | |
| – | – | – | -5.94 | -4.83 | -4.42 | -0.71 | -0.08 | -0.19 | -0.46 | -1.02 | -2.39 | -2.65 | -2.40 | -2.28 | -1.10 | -1.14 | -1.42 | -1.41 | -1.44 | -1.08 | -1.01 | -0.95 | -0.54 | -0.62 | -0.28 | 0.21 | -0.06 | 0.36 | 0.46 | 0.65 | 1.02 | 0.95 | 0.93 | |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.